Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii

被引:148
作者
Vila, J
Ruiz, J
Goni, P
deAnta, TJ
机构
[1] Department of Microbiology, School of Medicine, University of Barcelona, 08036 Barcelona
[2] Laboratorio de Microbiologia, Hospital Clínic, Universitat de Barcelona, 08036 Barcelona, Villarroel
关键词
D O I
10.1093/jac/39.6.757
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Mutations in the parC gene, which encodes a subunit of topoisomerase IV, were determined in 21 epidemiologically unrelated clinical isolates of Acinetobacter baumannii. Our studies highlight the conserved sequences in the quinolone-resistance-determining region of the parC gene from A. baumannii and other bacteria. Nine of ten isolates with MICs of ciprofloxacin of greater than or equal to 32 mg/L showed a change of Ser80 to Leu and one showed a change of Glu84 to Lys. These results suggest that ParC from A. baumannii is a secondary target for quinolones and that mutations at residues Ser80 and Glu84, when combined with mutations at Ser83 of GyrA, may render A, baumannii highly resistant to quinolones.
引用
收藏
页码:757 / 762
页数:6
相关论文
共 37 条
[1]  
Acar J F, 1993, Drugs, V45 Suppl 3, P24
[2]   OUTER-MEMBRANE PERMEABILITY IN PSEUDOMONAS-AERUGINOSA - COMPARISON OF A WILD-TYPE WITH AN ANTIBIOTIC-SUPERSUSCEPTIBLE MUTANT [J].
ANGUS, BL ;
CAREY, AM ;
CARON, DA ;
KROPINSKI, AMB ;
HANCOCK, REW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (02) :299-309
[3]   NEISSERIA-GONORRHOEAE ACQUIRES MUTATIONS IN ANALOGOUS REGIONS OF GYRA AND PARC IN FLUOROQUINOLONE-RESISTANT ISOLATES [J].
BELLAND, RJ ;
MORRISON, SG ;
ISON, C ;
HUANG, WM .
MOLECULAR MICROBIOLOGY, 1994, 14 (02) :371-380
[4]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[5]   TAXONOMY OF THE GENUS ACINETOBACTER WITH THE RECOGNITION OF ACINETOBACTER-BAUMANNII SP-NOV, ACINETOBACTER-HAEMOLYTICUS SP-NOV, ACINETOBACTER-JOHNSONII SP-NOV, AND ACINETOBACTER-JUNII SP-NOV AND EMENDED DESCRIPTIONS OF ACINETOBACTER-CALCOACETICUS AND ACINETOBACTER-LWOFFII [J].
BOUVET, PJM ;
GRIMONT, PAD .
INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1986, 36 (02) :228-240
[6]   NOVEL GYRA POINT MUTATION IN A STRAIN OF ESCHERICHIA-COLI RESISTANT TO FLUOROQUINOLONES BUT NOT TO NALIDIXIC-ACID [J].
CAMBAU, E ;
BORDON, F ;
COLLATZ, E ;
GUTMANN, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1247-1252
[7]   ENDOGENOUS ACTIVE EFFLUX OF NORFLOXACIN IN SUSCEPTIBLE ESCHERICHIA-COLI [J].
COHEN, SP ;
HOOPER, DC ;
WOLFSON, JS ;
SOUZA, KS ;
MCMURRY, LM ;
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1187-1191
[8]   CROSS-RESISTANCE TO FLUOROQUINOLONES IN MULTIPLE-ANTIBIOTIC-RESISTANT (MAR) ESCHERICHIA-COLI SELECTED BY TETRACYCLINE OR CHLORAMPHENICOL - DECREASED DRUG ACCUMULATION ASSOCIATED WITH MEMBRANE-CHANGES IN ADDITION TO OMPF REDUCTION [J].
COHEN, SP ;
MCMURRY, LM ;
HOOPER, DC ;
WOLFSON, JS ;
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1318-1325
[9]   CLONING AND PRIMARY STRUCTURE OF STAPHYLOCOCCUS-AUREUS DNA TOPOISOMERASE-IV - A PRIMARY TARGET OF FLUOROQUINOLONES [J].
FERRERO, L ;
CAMERON, B ;
MANSE, B ;
LAGNEAUX, D ;
CROUZET, J ;
FAMECHON, A ;
BLANCHE, F .
MOLECULAR MICROBIOLOGY, 1994, 13 (04) :641-653
[10]   ANALYSIS OF GYRA AND GRLA MUTATIONS IN STEPWISE-SELECTED CIPROFLOXACIN-RESISTANT MUTANTS OF STAPHYLOCOCCUS-AUREUS [J].
FERRERO, L ;
CAMERON, B ;
CROUZET, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1554-1558